These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Marburg and Ebola virus infections in laboratory non-human primates: a literature review. Schou S; Hansen AK Comp Med; 2000 Apr; 50(2):108-23. PubMed ID: 10857001 [TBL] [Abstract][Full Text] [Related]
14. Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Barnes KG; Lachenauer AE; Nitido A; Siddiqui S; Gross R; Beitzel B; Siddle KJ; Freije CA; Dighero-Kemp B; Mehta SB; Carter A; Uwanibe J; Ajogbasile F; Olumade T; Odia I; Sandi JD; Momoh M; Metsky HC; Boehm CK; Lin AE; Kemball M; Park DJ; Branco L; Boisen M; Sullivan B; Amare MF; Tiamiyu AB; Parker ZF; Iroezindu M; Grant DS; Modjarrad K; Myhrvold C; Garry RF; Palacios G; Hensley LE; Schaffner SF; Happi CT; Colubri A; Sabeti PC Nat Commun; 2020 Aug; 11(1):4131. PubMed ID: 32807807 [TBL] [Abstract][Full Text] [Related]
15. Lassa, Marburg and Ebola: newly described African fevers. Seah SK Can Med Assoc J; 1978 Feb; 118(4):347-8, 350. PubMed ID: 564739 [No Abstract] [Full Text] [Related]
16. Characteristics of Filoviridae: Marburg and Ebola viruses. Beer B; Kurth R; Bukreyev A Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977 [TBL] [Abstract][Full Text] [Related]
17. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522 [TBL] [Abstract][Full Text] [Related]
18. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. Goba A; Khan SH; Fonnie M; Fullah M; Moigboi A; Kovoma A; Sinnah V; Yoko N; Rogers H; Safai S; Momoh M; Koroma V; Kamara FK; Konowu E; Yillah M; French I; Mustapha I; Kanneh F; Foday M; McCarthy H; Kallon T; Kallon M; Naiebu J; Sellu J; Jalloh AA; Gbakie M; Kanneh L; Massaly JL; Kargbo D; Kargbo B; Vandi M; Gbetuwa M; Gevao SM; Sandi JD; Jalloh SC; Grant DS; Blyden SO; Crozier I; Schieffelin JS; McLellan SL; Jacob ST; Boisen ML; Hartnett JN; Cross RW; Branco LM; Andersen KG; Yozwiak NL; Gire SK; Tariyal R; Park DJ; Haislip AM; Bishop CM; Melnik LI; Gallaher WR; Wimley WC; He J; Shaffer JG; Sullivan BM; Grillo S; Oman S; Garry CE; Edwards DR; McCormick SJ; Elliott DH; Rouelle JA; Kannadka CB; Reyna AA; Bradley BT; Yu H; Yenni RE; Hastie KM; Geisbert JB; Kulakosky PC; Wilson RB; Oldstone MB; Pitts KR; Henderson LA; Robinson JE; Geisbert TW; Saphire EO; Happi CT; Asogun DA; Sabeti PC; Garry RF; J Infect Dis; 2016 Oct; 214(suppl 3):S110-S121. PubMed ID: 27402779 [TBL] [Abstract][Full Text] [Related]
19. The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses. Mattiuzzo G; Bentley EM; Page M Viruses; 2019 Aug; 11(9):. PubMed ID: 31450611 [TBL] [Abstract][Full Text] [Related]
20. [How to treat a patient with indications for an infectious viral hemorrhagic fever]. Visser LG; Schippers EF; Swaan CM; van den Broek PJ Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2183-8. PubMed ID: 12467160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]